Business Standard -- Drug major Lupin Ltd today said it has entered into a licensing pact for various patents of cholesterol lowering drug ‘Antara’ capsules with US-based Abbott Laboratories and France’s Laboratoires Fournier SA.
Lupin and its subsidiaries Lupin Pharmaceuticals Inc and Lupin Atlantis Holding SA, have entered into a licence agreement with Abbott Laboratories and Laboratoires Fournier SA for various Abbott patents for Antara (Fenofibrate) capsules, the company said in a statement.
